SCHEMBL11505730

SCHEMBL11505730

CCCCO[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.65

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ GJB2 P29033 5/20 0.53
▸ IGF2R P11717 6/20 0.47
▸ MAPK1 P28482 1/20 0.43
▸ LGALS8 O00214 1/20 0.42
▸ LGALS3 P17931 1/20 0.42
▸ LGALS4 P56470 1/20 0.42
▸ CETP P11597 1/20 0.41
▸ GBA1 P04062 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11505424 0.90 IGF2R (0.49) GJB2IGF2RCA1CA2CA9
Hydrochloric Acid SCHEMBL11759590 0.88 IGF2R (0.48) GJB2IGF2RCA1CA2CA9
SCHEMBL11505190 0.87 GJB2 (0.51) GJB2MAPK1GBA1CA1CA2
SCHEMBL11505189 0.87 GJB2 (0.51) GJB2MAPK1GBA1CA1CA2
SCHEMBL12406767 0.86 IGF2R (0.48) GJB2IGF2RMAPK1LGALS8LGALS3
SCHEMBL12406782 0.86 IGF2R (0.48) GJB2IGF2RMAPK1LGALS8LGALS3
Butylalphaman SCHEMBL2447224 0.85 MAPK1 (0.57) IGF2RMAPK1LGALS8LGALS3LGALS4
Butylalphaman SCHEMBL2447696 0.85 MAPK1 (0.57) IGF2RMAPK1LGALS8LGALS3LGALS4
Butylalphaman SCHEMBL2444941 0.85 MAPK1 (0.57) IGF2RMAPK1LGALS8LGALS3LGALS4
Butylalphaman SCHEMBL2554532 0.85 MAPK1 (0.57) IGF2RMAPK1LGALS8LGALS3LGALS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4156777-A FROM AN AMINO-GLUCOPYRANOSE AND O-NITRO OR -CYANO-PHENYL N-SUBSTITUTED-N-NITROSOCARBAMATE; ANTITUMOR AGENTS TOKYO TANABE COMPANY, LIMITED (JP) 1979-05-29 — — US disclosed
Send feedback